Controlled synthetic drug samples (U.S. Schedule 5 to Schedule 1) and non-controlled samples are used. Each test involves the qualitative analysis of two samples - one or both could be a controlled synthetic substance. This test is limited to synthetic drugs of the following classifications: synthetic cannabinoids, cathinones, tryptamines, phenethylamines, arylcyclohexylamines, benzodiazepine derivatives, nitazenes, or piperazines.

U.S. laboratories must provide a DEA registration number; enrollment will not be processed without it.

International laboratories will be notified via e-mail of the actual drug, quantity to be shipped, and the deadline for receiving the appropriate paperwork. Therefore, you must provide CTS with a reliable and secure e-mail address for a contact within your laboratory who will NOT be doing the testing. CTS will then request: 1) an original import permit, if required by your country; and 2) an original signed statement from the laboratory indicating that the drug samples will be used for scientific purposes only and will not be re-exported from the country of destination. CTS cannot ship your Synthetic Drug Analysis order without receiving both of those items.

This test is included on CTS' Scope of Accreditation to ISO/IEC 17043.

Samples ship in July.

Enrollment deadline: 15 March 2025